Expertise in
2
conditions

Dr. Vimal H. Prajapati

Pediatrics
Boston Children's Hospital
300 Longwood Ave, 
Boston, MA 
Accepting New Patients
Referral may be required
Before you request
Expertise in
2
conditions
Boston Children's Hospital
300 Longwood Ave, 
Boston, MA 

Overview

Vimal Prajapati is a Pediatrics provider practicing medicine in Boston, Massachusetts.

Dr. Prajapati is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Plaque Psoriasis, Generalized Pustular Psoriasis (GPP), and Neuroendocrine Tumor.

He is actively involved in clinical research, co-authoring 130 peer reviewed articles and participating in 5 clinical trials. Dr. Prajapati is currently accepting new patients.

Specialties

Pediatrics

Licenses

Pediatric Dermatology in MA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Boston Children's Hospital
300 Longwood Ave, Boston, MA 02115

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: November 05, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: September 18, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-controlled, Phase 2B Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
A Randomized, Double-blind, Placebo-controlled, Phase 2B Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: July 03, 2023
Intervention Type: Drug
Study Phase: Phase 2
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: February 24, 2023
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis
Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: September 27, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

130 Total Publications

Prevalence of Regulatory Safety Risk Factors Among Adolescents and Adults With Atopic Dermatitis Receiving Advanced Systemic Therapies: An International Real-World Study.
Prevalence of Regulatory Safety Risk Factors Among Adolescents and Adults With Atopic Dermatitis Receiving Advanced Systemic Therapies: An International Real-World Study.
Journal: International journal of dermatology
Published: July 02, 2026
Similar Doctors
Expertise in
72
conditions
Dr. Fowzan S. Alkuraya
Pediatrics | Medical Genetics
Expertise in
72
conditions
Dr. Fowzan S. Alkuraya
Pediatrics | Medical Genetics
Referral may be required
300 Longwood Ave, Fegan 10, 
Boston, MA 
 (0.1 miles away)
617-355-6000
Languages Spoken:
English

Fowzan Alkuraya is a Pediatrics specialist and a Medical Genetics provider practicing medicine in Boston, Massachusetts. Dr. Alkuraya is highly rated in 72 conditions, according to our data. His clinical expertise encompasses Achalasia Microcephaly Syndrome, Microcephaly, Early Infantile Epileptic Encephalopathy, Cortical Dysplasia, and Vitrectomy.

Expertise in
3
conditions
Expertise in
3
conditions
Referral may be required

The Dialysis Center At Waltham

135 Beaver St, 
Waltham, MA 
 (6.1 miles away)
781-419-4745
Languages Spoken:
English

Kenneth Huttner is a Pediatrics provider practicing medicine in Waltham, Massachusetts. Dr. Huttner is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Clouston Syndrome, Aplasia Cutis Congenita, and Ectodermal Dysplasias.

Expertise in
1
conditions
Expertise in
1
conditions
Referral may be required

Massachusetts General Hospital

55 Fruit St, 
Boston, MA 
 (2.6 miles away)
617-726-2066
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Katharine Zuckerman is a Pediatrics provider practicing medicine in Boston, Massachusetts. Dr. Zuckerman is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Autism Spectrum Disorder. Dr. Zuckerman is currently accepting new patients.

Frequently Asked Questions about Dr. Vimal H. Prajapati

How do I make an appointment with Dr. Vimal H. Prajapati?

You can book an appointment with Dr. Vimal H. Prajapati by calling their office at 617-580-1982. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Vimal H. Prajapati a top-rated expert for Plaque Psoriasis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Vimal H. Prajapati is classified as an Elite expert for Plaque Psoriasis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Vimal H. Prajapati specialize in?

While Dr. Vimal H. Prajapati is a Pediatrics, they have specific expertise in Plaque Psoriasis, Generalized Pustular Psoriasis (GPP), and Neuroendocrine Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatrics.

Does Dr. Vimal H. Prajapati participate in research or clinical trials?

Yes. Dr. Vimal H. Prajapati has published 130 articles and abstracts on conditions like Plaque Psoriasis. You can view a list of Dr. Vimal H. Prajapati's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Prajapati's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile